These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30054622)

  • 1. Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors.
    Singh S; Moody L; Chan DL; Metz DC; Strosberg J; Asmis T; Bailey DL; Bergsland E; Brendtro K; Carroll R; Cleary S; Kim M; Kong G; Law C; Lawrence B; McEwan A; McGregor C; Michael M; Pasieka J; Pavlakis N; Pommier R; Soulen M; Wyld D; Segelov E;
    JAMA Oncol; 2018 Nov; 4(11):1597-1604. PubMed ID: 30054622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive gastro-entero-pancreatic neoplasms.
    Coriat R
    Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].
    Luley K; Gebauer J; Gebauer N; Tharun L; Buchmann I; Barkhausen J; von Bubnoff N; Lindner K; Keck T; Lehnert H; Schmid SM
    Internist (Berl); 2020 Aug; 61(8):875-890. PubMed ID: 32676723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors.
    Singh S; Chan DL; Moody L; Liu N; Fischer HD; Austin PC; Segelov E
    JAMA Oncol; 2018 Apr; 4(4):583-585. PubMed ID: 29543939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
    Perez K; Chan J
    Surg Pathol Clin; 2019 Dec; 12(4):1045-1053. PubMed ID: 31672293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS).
    Chan DL; Moody L; Segelov E; Metz DC; Strosberg JR; Pavlakis N; Singh S
    Neuroendocrinology; 2018; 107(1):32-41. PubMed ID: 29539613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.
    Garcia-Carbonero R
    Cancer Metastasis Rev; 2014 Mar; 33(1):343-4. PubMed ID: 24357057
    [No Abstract]   [Full Text] [Related]  

  • 8. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
    Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of gastro-entero-pancreatic neuroendocrine tumours (GEP NET): an introduction.
    Van Hootegem P; Borbath I; Verslype C
    Acta Gastroenterol Belg; 2009; 72(1):27-8. PubMed ID: 19402367
    [No Abstract]   [Full Text] [Related]  

  • 10. [Surgical treatments for gastroenteropancreatic neuroendocrine tumor (GEP-NET)].
    Aoki T; Kokudo N
    Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2272-9. PubMed ID: 25482902
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of neuroendocrine tumors.
    Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Phan AT; Kunz PL; Reidy-Lagunes DL
    Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.
    Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A
    Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour grade and primary site predict patterns of recurrence and survival in patients with resected gastroenteropancreatic neuroendocrine tumors.
    Watanabe A; Yip L; Hamilton TD; Loree JM; Stuart HC
    Am J Surg; 2021 Jun; 221(6):1141-1149. PubMed ID: 33795127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastroenteropancreatic neuroendocrine tumor microenvironment and related therapy].
    Ye C; Yuan CH; Li G; Zheng L; Xiu DR
    Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):866-871. PubMed ID: 31694137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroenteropancreatic neuroendocrine tumors: Role of surgery.
    Sauvanet A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):175-181. PubMed ID: 31079831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)].
    Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1305-1329. PubMed ID: 36575783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology and Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
    Raj N; Fazio N; Strosberg J
    Am Soc Clin Oncol Educ Book; 2018 May; 38():292-299. PubMed ID: 30231344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.